Historical analysis: this article examines information published by the source on September 16, 2022. This site’s publication date is shown separately. Check the latest vendor guidance before acting.
What happened
Guidance provided by the 405(d) program emphasizes the necessity of regular system updates—patching—to remove vulnerabilities that could be exploited by attackers. The source highlights that patching modifies software applications, making it more difficult for unauthorized actors to maintain programs aligned with current software versions.
Who may be affected
This guidance is directed toward small healthcare organizations, including those managing connected medical devices and systems.
Why it matters
Failure to implement a consistent patching cadence can leave healthcare environments exposed to several risks:
* Patient Safety: Vulnerabilities in connected medical devices could be targeted, potentially impacting clinical care.
* Operational Continuity: Unpatched systems are susceptible to ransomware attacks.
* Data Integrity: Security gaps increase the risk of accidental or intentional data loss from both internal and external sources.
Mitigation priorities
Based on the provided guidance, healthcare organizations should prioritize the following actions:
- Establish a Monthly Patch Cycle: Implement vendor-provided patches at least monthly to reduce the window of exposure.
- Address End-of-Life (EOL) Systems: Identify and remove or upgrade software and operating systems that are no longer supported by the manufacturer, as these cannot be patched.
- Prioritize High-Severity Vulnerabilities: Use standardized measurements, such as those from the National Vulnerability Database (NVD), to rank and address the most severe vulnerabilities first based on the organization’s risk tolerance.
- Medical Device Coordination: Ensure medical devices are updated using patches released specifically by the device manufacturers. This requires coordination between IT operations and clinical engineering to perform regression testing, ensuring updates do not negatively impact clinical functions before deployment during scheduled change windows.
How to verify mitigation
Our recommended validation approach:
* Application Verification: We advise organizations to validate that patches have been successfully applied to the intended assets rather than assuming success based on a deployment tool’s report.
* Residual Risk Assessment: After standard patching, we recommend classifying and prioritizing vulnerabilities that remain (e.g., those requiring configuration changes or full version upgrades) as these are more complex to resolve.
* Authorized Testing: For medical devices, we recommend agreeing upon a safe, authorized retest with the system owner and clinical engineering team following any update to ensure device functionality remains intact.
What remains uncertain
The source does not provide specific technical instructions for performing regression tests on medical devices or detailed criteria for determining an organization’s specific “level of risk tolerance” when deciding which vulnerabilities to prioritize.
Source and editorial note
How to Implement Patching (Small organizations) · Source date: September 16, 2022 · Retrieved August 31, 2026.
Original analysis prepared with local AI and automated relevance and evidence checks. These checks are not a guarantee of accuracy. Recommendations are our defensive analysis unless attributed to the source.
Request a healthcare security assessment
Protect the systems your care depends on.
Discuss your healthcare environment, prioritize exposure, and establish evidence that safeguards work.
Request a healthcare assessment ↗